Financial Statements · Financial Reporting

AS "Repharm"

Official identifier 40103195532
Latvia

Dates

Reporting Year
2022

Financial facts

Employees
2
Currency
EUR
Total assets
112,223,998
Equity
83,629,310
Current liabilities
28,594,688
Non-current liabilities
0
Net turnover
0
Net income
81,391,821

Linked company

Company: AS "Repharm"

Source

Financial Statements

View published source

Back to Financial Statements